InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: RockoTaco post# 94907

Tuesday, 09/03/2019 2:41:33 PM

Tuesday, September 03, 2019 2:41:33 PM

Post# of 140475
Rocko, thanks for sharing these observations. I have an additional takeaway, or maybe an amplification for one of your points...

With all the griping folks do about Titan, how come we know that Titan finished Human Factors and GLP studies and we know what their Q3 and Q4 and H1 plans are with such a LACK OF TRANSPARENCY? Is anyone beating up on Medtronic or JnJ or Stryker or Verb for LACK OF TRANSPARENCY? Oh, wait... for those folks, they are allowed to maintain industrial secrecy while Titan gets publicly hammered for it here on iHub, even when they don't practice it at all. They are forthcoming with their plans, but beat up for LACK OF TRANSPARENCY! Why? I have no idea.

On a possibly unrelated note, I wonder what the short percentages are for Medtronic and JnJ and Stryker and... And Titan, of course, by comparison to their competitors.


Message in reply to:
Titan is less then 30 days away from Q4 - which includes IDE approval and regulatory submittal. They just completed GLP and human factors. They will be doing human clinical trials as well as 510k submission


Interesting point - we here nothing from
Medtronic or JNJ or Stryker or any biggun about their GLP or their IDE process or their human clinical trials or their regulatory submittal.

Titan is not only the next closest platform to get approved BUT they are way ahead of Medtronic and JNJ when it comes to SINGLE PORT.